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The aim of this study was to verify whether L-lactide/DL-lactide copolymer 80/20 (PLDLLA) and platelet-rich plasma (PRP)
trigger bone formation within critical-sized calvarial defects in adult sheep (𝑛 = 6). Two craniectomies, each ca. 3 cm in
diameter, were created in each animal. The first craniectomy was protected with an inner polylactide membrane, filled with
PRP-polylactide granules, and covered with outer polylactide membrane. The second control craniectomy was left untreated.
The animals were euthanized at 6, 7, 17, 19, 33, and 34 weeks after surgery, and the quality and the rate of reossification were
assessed histomorphometrically andmicrotomographically.The study demonstrated that application of implants made of PLDLLA
80/20 combined with an osteopromotive substance (e.g., PRP) may promote bone healing in large calvarial defect in sheep. These
promising proof-of-concept studies need to be verified in the future on a larger cohort of animals and over a longer period of time
in order to draw definitive conclusions.
1. Introduction
Skull bone reconstruction is frequently performed within
departments of neurosurgery as some neurosurgical proce-
dures require craniectomy. Restoration of skull integrity is a
vital procedure, as it protects fragile neural structures against
injury, provides appropriate dynamics of cerebrospinal flow,
and prevents ischemia caused by herniation of the brain into
the craniectomy. Skull defects can be repaired with autolo-
gous bone grafts or synthetic materials. The most popular
synthetic nonresorbable material is polymethyl methacrylate
(PMMA) used as bone cement (i.e., polymerized in situ
from methyl methacrylate monomer and polymer powder
mixture), as well as a bulk polymer implant material. PMMA
is considered a reliable and inexpensive implant material,
but it may cause local toxicity and become encapsulated by
fibrous tissue. Furthermore, nonresorbable synthetic mate-
rials pose a 10–40% risk of infection or graft rejection
[1, 2]. In turn, the use of frozen autologous bone grafts,
aside from a 25% risk of infection, is also associated with
up to 15% risk of bone flap resorption [3]. Therefore,
against this background, novel alternatives for autologous
grafts and nonresorbable synthetic materials are urgently
required. Ideally, it should be synthetic resorbable material
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Table 1: Physicochemical and mechanical parameters of investigated membrane implants.
Physicochemical parameters Mechanical parameters
Wettability
Θ [∘]
Roughness
𝑅𝑎 [𝜇m]
Tensile strength
𝑅𝑚 [MPa]
Young’s modulus
𝐸 [GPa]
PLDLLA
membrane 78.4 ± 2.53 1.52 ± 0.12 48.5 ± 2.98 2.32 ± 0.32
PLDLLA: L-lactide and DL-lactide copolymer (poly-L/DL-lactide).
or nanocomposite (polymer-ceramic) based on biodegrad-
able polymer scaffolds and bioactive ceramic fillers [4–11].
One of the most promising materials so far are polylactide
copolymers and several groups have already demonstrated
their osteogenic properties and capabilities of healing bone
defects [12–20]. Polylactide copolymers exist as two isomeric
forms, L-polylactide and D-polylactide. Polymerization of a
racemic L-lactide and D-lactide mixture results in synthesis
of amorphous poly-DL-lactide. Up to date, two forms of the
copolymer, with 80% to 20% and 70% to 30% L-lactide to
DL-lactide ratio, have found application in experimental and
clinical studies. Of note, the first has greater strength, better
dimensional stability, and higher degree of crystallinity and
biodegradability [14, 21].
Even though the previous studies have demonstrated
usefulness of polylactide polymers in reconstruction of small
bone defects, their applicability in the treatment of larger
defects still remains an open question. This might be due
to the fact that their osteoconductive and osteoinductive
properties are not as good as those of autologous bones.
As a result, resorption of a synthetic material used
to fill the defect is not counterbalanced by the syn-
thesis of the new bone, which may eventually lead to
pathological fractures or nonintegration in the vicinity
of the graft [22]. Consequently, synthetic reconstructive
materials should be applied together with osteoinduc-
tive/osteogenic materials, such as platelet-rich plasma (PRP)
and its derivatives (PRGF, plasma-rich growth factors; PRF,
platelet-rich fibrin) or mesenchymal stem cells derived
from bone marrow/connective/adipose/dental tissues [23–
27]. Several animal and human studies demonstrated that
bone marrow/adipose/dental-derived mesenchymal stem
cells/PRF promote bone growth, due to the ability of mes-
enchymal cells to transform into osteoblasts or under the
influence of growth factors released from platelets that
may stimulate processes responsible for bone healing (e.g.,
mitogenesis, chemotaxis, and cell differentiation) [23–25, 28–
31]. Both PRP and its derivatives/mesenchymal cells are
currently widely used as a stimulator of bone healing during
reconstructive procedures in maxillofacial surgery [23–25,
32–34].
Herein, we present the proof-of-concept experiment that
focuses on regeneration of large bone defects using synthetic
materials with established osteoconductive properties (e.g.,
polylactide and calcium triphosphate), in a form of com-
posite, along with osteoinductive substances, such as bone
marrow and/or PRP. The aim of this study was to investigate
the process of bone formation within L-lactide/DL-lactide
copolymer 80/20 (PLDLLA) and PRP-filled critical calvarial
defects in a medium-sized animal (sheep).
2. Materials and Methods
2.1. Animals. The experiment was performed using six adult
female Merino sheep (Ovis aries), aged approximately three
years, with 70–80 kg body weight. The animals were kept
in an appropriately adapted room and fed with a standard
laboratory diet.The protocol of the studywas approved by the
Animal Research Ethics Committee at theMedical University
of Silesia (decision number 55/2010).
2.2. Implants. A commercially available FDA-attested basic
80/20 PLDLLA polymer (PURAC Biochem, Gorinchem,
Netherlands) with molecular weight of ca. 200 kDa was
used. Neat polymer was processed and tested in two forms,
membrane and porous granules. Thin (350 𝜇m) polymer
membranes were obtained by a 10min hot pressing of
polymer beads in a stainless form (4 × 12 cm) at 160∘C.
Topography of the membrane surface was examined
goniometrically (HOMMEL TESTER T500, Germany). The
results are expressed as mean surface roughness (𝑅𝑎) deter-
mined during 10 repeated measurements, along with stan-
dard deviation (SD).Wettability (Θ) of the composite surface
was determined directly (DSA 10, Kru¨ss GmbH, Germany).
The measurements were taken at room temperature (RT),
using high-purity water (PURELAB UHQ, Vivendi Water,
UK) as a measuring liquid. Microstructure of the membrane
was examined using a scanning electron microscope (Nova
NanoSEM, FEI, USA). Mechanical parameters of the mem-
brane, such as tensile strength (𝑅𝑚) and Young’s modulus
(𝐸), were measured with a tensile tester machine (Zwick
1435, Zwick Roell, Germany), with a parallel specimen length
and test speed of 40mm and 40mm/min, respectively. Six
measurements were taken for each sample. The results of the
measurements are summarized in Table 1.
Porous polymer granules with PLDLLA were
obtained using solvent casting and a specific leaching
method, with sodium dihydrogen phosphate hexahydrate
(NaH2PO4⋅6H2O, Avantor S.A., Poland) as a porogene.
Two fractions of slat particles, 100𝜇m and 300 𝜇m at 1 : 2
ratio, were used during the preparation process. During the
first step, PLDLLA was dissolved in acetone (CH3COCH3,
Avantor S.A., Poland; 1 : 6 polymer to solvent ratio) at RT for
24 h. Then the solution was mixed with salt particles at 1 : 35
ratio (dry mass of PLDLLA to NaH2PO4⋅6H2O content) with
the aid of amechanical stirrer (30∘C/15min).Themixturewas
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Table 2: Microstructural and physical parameters of the porous granules.
Microstructural parameters Physical parameter
Porosity,
𝑃 [%]
Pore size,
𝑝 [𝜇m]
Specific surface area,
𝜎𝑚 [m
2/g]
Size of granules,
𝑑 [𝜇m]
Porous
granules ∼75 5–200 2.1 100–400
(a) (b)
Figure 1: SEM microphotographs of polylactide membrane surface (a) and porous polylactide granule (b).
air-dried for 72 h at 25∘C and then transferred to a vacuum
chamber at 25∘C for 24 h. Then, the salt particles were
dissolved in water (20∘C) until ion conductivity of the water
bath contents, monitored with pH-meter (CP400, Elmetron,
Poland), reached that of pure water (i.e., 3.5𝜇m/cm). Only
the granules with 100 to 400 𝜇m diameters were chosen for
further experiments. Dimensions (𝑑) of the porous granules
and their morphological characteristics were determined
with Mastersizer 2000 (Malvern Instruments Ltd., UK) and
Nova NanoSEM (FEI, USA), respectively. Total porosity
(𝑃) and pore size (𝑝) were measured by means of mercury
porosimetry (PoreMaster 60, Quantachrome Instruments,
USA). Also, specific surface area (𝜎𝑚) of the granules was
determined. All the above-mentioned parameters of porous
granules are presented in Table 2 and Figure 1.
2.3. PRP Preparation. A few minutes before introduction
of anesthesia, 25ml blood sample was obtained from the
external jugular vein of each animal. The samples were
collected to silicone vials with 0.5ml 3.2% sodium citrate and
centrifuged at 2,400 rpm for 10min (MPW-341 centrifuge,
MPWMed. Instruments, Warsaw, Poland). As a result, three
layers of blood components were obtained: the bottom layer
containing erythrocytes, a top layer of plasma with a trace
number of platelets, that is, the so-called platelet-poor plasma
(PPP), and a white intermediate layer of PRP with a trace
amount of leukocytes. Then, the layer of PPP was pipetted
to new vials and further centrifuged at 5,000 rpm for 10min.
After pooling PRP from the first and second centrifugation,
ca. 1.5ml aliquots were obtained with 2.4-fold greater mean
platelet density than in the source whole blood sample.
Upon adding ca. 20 𝜇L 10% calcium chloride solution (CaCl2,
Avantor S.A., Poland) to activate the platelets, PRP was
mixed with polylactide granules to form a gel that was used
during surgical procedures. Amount of the granules was
about 400𝜇g, while volume of the polymer granules mixed
with PRP and tightly packed during craniotomy was about
3.5ml.
2.4. Surgical Procedure. Peripheral catheters were inserted
into both external jugular veins of each animal. Anesthe-
sia was introduced with atropine (1mg, Atropinum Sul-
furicum 1mg/ml injection, Polfa Warszawa, Poland) and
ketamine (1mg per kg body weight, usually 70mg, Ketan-
est 50mg/ml, Pfizer Europe, UK), followed by thiopental
(1 g dissolved in 20ml 0.9% NaCl, Thiopental Injection
BP 500mg, Rotexmedica GmbH, Germany) and fentanyl
(0.1mg, Fentanyl WZF, 50 𝜇g/ml injection, Polfa Warszawa,
Poland). Then, the animal was intubated with the aid of a
laryngoscope, an inhalation anesthetic device was connected
to the tracheal tube, and general inhalation anesthesia with
isoflurane (Aerrane 250ml, Baxter, Poland) was introduced
gradually, initially at 2%, and lowered to 1–1.5% concen-
tration. A single intravenous injection of cefazolin (1 g,
Biofazolin for Injection USP 1 g, Polpharma, Poland) was
given as a perioperative antibiotic prophylaxis.
After preparation of the surgical field, a T-shaped skin
incision was made, with a transverse incision along the
biauricular line and shorter midline incision oriented cau-
dally. Then, a cutaneoaponeurotic flap was separated from
the calvarium with a monopolar electric knife, and two
craniectomies, each ca. 3 cm in diameter, were made in the
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Figure 2: Sagittal cross section of ovine skull and intraoperative
photograph of two calvarial craniectomies. DM: dura mater.
right and left frontoparietal regions, next to the sagittal line,
without compromising the dura mater (Figure 2). Due to
specific anatomical conditions of calvarium in adult female
sheep, we were unable to create more than two critical
openings. One craniectomy in each animal was left empty
as the control, whereas the second one was filled with the
polylactide porous granules and PRP as described below.
One of the polylactide membranes, adjusted for the size
and shape of the opening, was placed at the craniectomy
bottom. Then, the defect was filled with the gel composed
of PRP and polylactide granules and covered with another
polylactide membrane, with the diameter being 5mm larger
than that of the craniectomy opening. The outer membrane
was fixed to the bone at three points, with sutures placed in
previously drilled small holes. The procedure of filling the
defectwith polylactide is presented schematically onFigure 3.
During the last stage of the procedure, after achieving
hemostasis, the skin woundwas closedwithmultiple layers of
stitches, and a hydrocolloid gel with stabilized silver complex
(Hydrosil-Flamozil, Sequoia Sp. z o.o., Poland) was applied to
prevent bacterial infection and to facilitate healing.
After the procedure, all animals were kept under the same
conditions as preoperatively and fed with a standard labora-
tory diet. None of the animals presented with fever or signs
of infection. Skin stitches were removed 7 days after surgery.
First intention healing was achieved in all cases. To analyze
the influence of time on bone regeneration, the animals were
euthanized consecutively at 6, 7, 17, 19, 33, and 34 weeks after
surgery; a ketamine injection (1mg per kg body weight) was
given followed by propofol infusion (200–400mg, Propofol
1% Fresenius, Fresenius Kabi Deutschland GmbH, Germany)
to cause loss of consciousness, respiratory depression, and
death.
2.5.Microscopic Analysis andHistomorphometry. A fragment
of the calvarium containing both primary and newly formed
bone from the regeneration site was obtained from each
animal. The specimens were transferred to the Department
of Pathology, Medical University of Silesia in Katowice,
whereby thin slices were cut from peripheral and central
portion of the regeneration area. The slices were fixed in a
1 : 1 mixture of 10% neutral buffered formalin (Bio-Optica
Milano S.p.A., Milan, Italy) and 10% aqueous EDTA solution
(tetrasodium versenate hydrate, Avantor S.A., Poland). After
decalcification, slices were rinsed with 70% ethanol and
cut into 5 𝜇m sections using a microtome (Hyrax M55,
Zeiss, Germany). Microscopic specimens were stained with
Masson’s trichrome. A total of 10microscopic specimenswere
prepared for each animal: 5 from the central portion and
5 from the peripheral portion of the regeneration site. The
specimens were examined at 200x under an Olympus BX53
Digital Upright Microscope (Olympus Deutschland GmbH,
Hamburg, Germany) and representative digital images were
analyzed by Image-Pro Plus 6.0 software (Media Cybernetics,
Inc., Rockville, USA). The total surface area of all five
specimenswas 738,840 𝜇m2. Computerized analysis included
identification and quantification of three components: bone
trabeculae, immature bone, and connective tissue. Bone tra-
beculae and the foci of immature bone tissue were quantified
in both the peripheral and central portions of each specimen;
specimen areas occupied by these components were deter-
mined, along with the area occupied by the connective tissue.
2.6. Microtomographic Analysis. During the next stage, bone
density was determined in the calvarium specimens. Cuboid
samples with dimensions adjusted to the skull bone thickness
in a given animal and mean volume of 350mm3 were
obtained from each specimen and examined using a high-
resolution micro-CT scanner (phoenix v|tome|x s, General
Electric Measurement & Control Solutions, Wunstorf, Ger-
many). Global thresholding at various levels was performed
in order to separately visualize soft and hard tissues by
segmentation.
2.7. Statistical Analysis. Statistical significance of differences
in the quality and rate of tissue reconstruction in central
and peripheral regions of the defect was verified with
the nonparametric Wilcoxon signed-rank test. Associations
between follow-up time and the area of newly formed
bone and between the latter parameter and hydroxyapatite
(HAp) density were studied on the basis of Spearman’s rank
correlation coefficient. Total areas occupied by newly formed
bone and connective tissue in specimens from two animals
euthanized at 6 and 7, 17 and 19, and 33 and 34 weeks
were compared with the Kruskal-Wallis test. All calculations
were carried out with STATISTICA 10 (StatSoft, Inc. (2011),
http://www.statsoft.com), with the threshold of statistical
significance set at 𝑝 < 0.05.
3. Results
3.1. Macroscopic Analysis and Imaging. As expected, there
were no signs of ossification in any of the control craniec-
tomies. All of them were filled with connective tissue, tightly
attached to the dura. Moreover, we found that their bone
edges underwent remodeling and resorption becoming more
rounded.
On the other hand, craniectomies filled with polylac-
tide/PRP gel showed the presence of irregular osteoid tissue,
slightly darker than surrounding primary bone (Figures 4(A),
4(B), and 4(C)).This osteoid tissuewas identified as amixture
of bone, connective tissue, and polylactide residues. The
resultant conglomerate adhered tightly to the bone edges of
craniectomy and kept a stable position within the defect.
Importantly, both polylactidemembranes retained theirmor-
phological integrity and showed no signs of degradation.
BioMed Research International 5
DM
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Figure 3: Consecutive stages of filling experimental craniectomy with polylactide implants and platelet-rich plasma (PRP). DM: dura mater;
PG: polylactide granules mixed with PRP; PM: polylactide membrane.
Figure 4: Ovine calvarial specimen (A), transverse cross sections of filled craniectomy ((B) and (C)), microtomographic images of peripheral
part (D) and central part (E) of filled craniectomy, and microphotographs of peripheral part (F) and central part (G) of filled craniectomy
(200x, Masson’s trichrome). DM: dura mater; S: suture; PM: polylactide membrane; B: calvarial bone; NB: newly formed bone in filled
craniectomy; Δ: interface of newly formed bone and craniectomy edge; BT: bone trabecula; IBT: immature bone tissue; CT: connective tissue;
PLA: polylactide.
6 BioMed Research International
Table 3: Comparison of histomorphometric and microtomographic parameters.
Animal
number
Follow-up
(weeks)
Absolute (𝜇m2) and relative (%)
contents of new bone in a
specimen∗∗
Absolute (𝜇m2) and relative (%)
contents of connective tissue in a
specimen∗∗
HAp density (g/cm3) and
corresponding percentage of reference
value∗
II 6 115 × 103 (7.8%) 156 × 103 (10.6%) 0.88 (58.7%)
V 7 122 × 103 (8.3%) 231 × 103 (15.6%) 0.97 (64.7%)
VI 17 123 × 103 (8.4%) 238 × 103 (16.1%) 1.02 (68.0%)
III 19 163 × 103 (11.1%) 238 × 103 (16.2%) 1.01 (67.3%)
IV 33 196 × 103 (13.3%) 287 × 103 (19.4%) 1.06 (70.7%)
I 34 206 × 103 (13.9%) 339 × 103 (22.9%) 1.14 (76.0%)
Data represent five specimens from the peripheral part and five specimens from the central part. HAp: hydroxyapatite.There is a significant positive correlation
between total area covered with newly formed bone and hydroxyapatite density (Spearman’s 𝑟 = 0.94; 𝑝 < 0.01). ∗HAp density in normal bone—1.50 g/cm3;
∗∗nonsignificant differences in histomorphometric findings determined at 6-7, 17–19, and 33-34 weeks (Kruskal-Wallis test).
Furthermore, the microtomographic studies revealed the
areas filled with mineralized bone. Some of these areas were
in direct contact with the bone edges of craniectomy, whereas
others appeared as islands of bone tissue spreadwithin central
parts of the defect (Figures 4(D) and 4(E)).
3.2. Histological and Microtomographic Analysis. Histolog-
ical analysis of specimens from craniectomies filled with
polylactide/PRP gel included 60 specimens stained with
Masson’s method, 10 per animal including 5 from the central
portion and 5 from the periphery of the defect. No signs of
inflammation associated with the infection or presence of a
foreign bodywere found in histological specimens. Represen-
tative microscopic images are presented on Figures 4(f) and
4(g). Individual data for microtomographically determined
HAp density and histomorphometrically determined areas
of ossification foci (i.e., bone trabeculae and nontrabecular
bone) and connective tissue are presented in Table 3.
Median values (along with the 25th and 75th percentiles)
for the number and area of ossification foci and the specimen
area covered with connective tissue for the central part of the
defect were 28 (24–37), 48 × 103 (38 × 103–76 × 103) 𝜇m2, and
176 × 103 (120 × 103–190 × 103)𝜇m2, and for its peripheral
portion 38 (27–55), 102 × 103 (69 × 103–136 × 103) 𝜇m2, and
84 × 103 (71 × 103–123 × 103) 𝜇m2, respectively. Central and
peripheral regions of the defect did not differ significantly in
terms of the number and the area of ossification foci and the
specimen area covered with connective tissue (Figures 5–7).
When the rate of tissue regeneration was stratified
according to observation time, mean amount of bone tissue
amounted to 119 × 103 𝜇m2 (i.e., 8% of histological specimen
surface) for 6 and 7 weeks, 143 × 103 𝜇m2 (i.e., 9.8%) for
17 and 19 weeks, and 201 × 103 𝜇m2 (i.e., 13.6%) for 33
and 34 weeks, whereas mean contents of connective tissue
were 193 × 103 𝜇m2 (i.e., 13.1%), 238 × 103 𝜇m2 (i.e., 16.1%),
and 313 × 103 𝜇m2 (21.1%), respectively (Table 3). In turn,
mean contents of bone tissue and connective tissue for all
histological specimens, irrespective of the observation time,
were 154 × 103 𝜇m2 (10.5%) and 248 × 103 𝜇m2 (16.8%),
respectively.
A significant positive correlation was found between total
area covered with newly formed bone and HAp density (𝑟 =
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Figure 5: Number of ossification foci (the sum of bone trabeculae
and immature bone tissue) in the peripheral and central parts of the
defect (Wilcoxon signed-rank test).
0.94; 𝑝 < 0.01) (Table 3). Moreover, a strong correlation (𝑟 =
0.95; 𝑝 < 0.01) was found between the area of ossification
foci in analyzed microscopic specimens and follow-up time
in weeks (Figure 8). There were no statistically significant
differences in the areas covered with newly formed bone and
connective tissue in specimens from 6 and 7, 17 and 19, and 33
and 34 weeks of follow-up (Table 3). This implies that, after
an initial intensive regeneration of bone tissue, this process
still progressed but at a substantially lower rate.
4. Discussion
The important parameters in the biocompatibility study of
each biomaterial, including polymers, are their surface and
their impact on the regeneration processes after implantation
BioMed Research International 7
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trabeculae and immature bone tissue) in the peripheral and central
parts of the defect (Wilcoxon signed-rank test).
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Figure 7: Area covered by connective tissue in the peripheral and
central parts of the defect (Wilcoxon signed-rank test).
[35]. The cell-biomaterial interactions are influenced by
surface morphology (porosity and roughness) and other
features of the surface layers (e.g., chemical composition and
physicochemical properties) which depend on the polymer
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Figure 8: Correlation between follow-up time and total specimen
area covered with newly formed bone (Spearman’s rank correlation
coefficient).
processing method (thermal history and additional physical,
chemical, or biological treatment). In order to develop a high-
quality biocompatible biomaterial, several sample features
need to be initially tested and standardized in vitro. For
example, Marrelli et al. have developed a computer-aided
design (CAD) project that used a standardized design to test
different types of scaffolds in order to provide a greater accu-
racy of the measurements in the assessment of the cellular
response on a biomaterial [36]. Our in vivo experiments were
preceded by in vitro tests that confirmed good biocompati-
bility of the porous form of PLDLLA-based biomaterial with
osteoblasts [37, 38]. Furthermore, we have also demonstrated
previously that both porosity and morphology of granules
and membranes are beneficial for the safe transfer of PRP
elements (i.e., growth factors) [39].
The current in vivo experiment has shown, in linewith the
previous findings [12, 14, 15, 17–19], that poly(L/DL-lactide)
80/20-based implants are biocompatible andwell tolerated by
host tissues. We observed no signs of adverse tissue reactions
such as infiltration of inflammatory cells or formation of
necrotic foci in the examined specimens.
In addition, we demonstrated that L/DL 80/20
polylactide-based implants promote bone regeneration
within medium-sized skull defects. We found ossification
foci in both the peripheral and central portions of the
defects already 6 weeks after implantation. During following
weeks, the amount of newly formed bone (bone trabeculae
and immature bone matrix) increased linearly (Figure 8),
suggesting that osteoinductive activity of PRP might have
been overlapped with an osteoconductive effect of porous
polylactide granules.
We did not find any significant differences in the amount
of bone trabeculae and immature bone matrix in the periph-
eral and central parts of the defect (Figures 5 and 6).However,
it is well known that ossification begins at the periphery of the
defect and progresses towards its central part, which is due
to the fact that periosteum and bone marrow are a primary
source for osteogenic cells during regeneration. Our findings
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imply that the rates of bone regeneration in the center and
periphery of the defect were essentially the same. Most likely,
osteogenesis in the central part of the defect was additionally
stimulated by osteogenic cells derived from dura mater or
by the connective tissue cells penetrating across the barrier
membrane and differentiating into osseous tissue. Of note, it
has been previously shown that connective tissue cells may
undergo transformation into osseous tissue, especially the
osteogenic factors that are released from the bone ends and/or
bone marrow present in the defect [18].
The histomorphometric analysis has shown that, at the
end of the experiment, in less than a year (at week 34), newly
formed ossification foci covered merely ca. 14% of the defect
(Table 3). However, the microtomographic analysis provided
more optimistic results, showing that the level of HAp, an
inorganic component of bone, reached up to 76% (Table 3).
High concentration of HAp within the defect most likely
resulted from the mineralization of the latter, stimulated by
addition of osteoinductive PRP. This indicates that the tissue
growing on the scaffold of polylactide granules enriched with
PRP may show similar durability to normal bone, providing
adequate regeneration of large skull defects. These results
are in line with data published by other authors who used
scaffolds made of ceramic biomaterials, such as HAp and
calcium triphosphate [6, 10, 11].
Although the differences in the amount of new bone at
three examined time points were not statistically significant
(Table 3), we found a strong correlation (𝑟 = 0.95; 𝑝 < 0.01)
between the area of ossification foci in histological specimens
and observation time expressed inweeks (Figure 8).This sug-
gests that although the rate of bone regeneration decreased
after an initial peak, the process was still progressing. This
observation is consistent with previously published studies,
in which the amount of newly formed bone increased
steadily with observation time, despite the lack of statistically
significant differences between the analyzed time points [10–
12, 15, 40].
A decrease in the rate of bone regeneration seems to be
a consequence of connective tissue ingrowth into the bone
defect. The technique of guided bone regeneration (GBR)
with barrier membranes covering the defect plays a key role
in the prevention of connective tissue ingrowth [12, 14, 15,
18, 19, 41–44]. The success of GBR technique depends on
physical support provided by the barrier membrane that
overlays the soft tissue and creates a space to be filled with
blood clot while excluding the competing nonosteogenic cells
from the defect and possibly allowing local accumulation
of the growth factors under the membrane [18]. A number
of authors reported successful application of GBR technique
in the treatment of small bone defects [5, 7, 12, 13, 18,
43, 45], including small calvarial defects [14–16, 19, 40–
42, 46]. In these studies, bone defects were covered with
membranes made of resorbable materials with good biocom-
patibility: polylactide, polyglycolide, copolymers of lactide
and glycolide [12–16, 18, 19, 42, 43], polyhydroxybutyrate acid
[45] or nonresorbable polytetrafluoroethylene [41], calcium
sulfate [5], and others [7, 46]. The most common type of
polylactide copolymer-based implants used in animal studies
was membranes made of poly(L-lactide), poly(D,L-lactide),
andpoly(L/DL-lactide) 70 : 30 and 80 : 20 [12, 14, 15, 18, 19, 43].
In the treatment of large bone defects aside from barrier
membranes, also fillers with established osseointegration
properties, 𝛽-tricalcium phosphate (𝛽-TCP) [4, 6, 11], HAp
[10, 47], biocompatible ceramic materials [5, 8, 9], and others
[7, 48], can be used along with osteopromotive materials,
such as bone marrow-derived mesenchymal stem cells and
PRP. However, if the barrier membranes degrade too rapidly,
they may lose their morphological integrity and physical
strength and eventually collapse inside the defect [41, 46].
The advantage of polylactide copolymer-based membranes
is relatively long degradation time, up to several months
[12, 18, 49]. Furthermore, the differences in biodegradability
between different types of the polylactide membranes do
not seem to exert a significant effect on bone regeneration
[14, 15, 50]. In our present study, although the membranes
made of PLDLLA 80/20 retained their integrity and elasticity,
still promoting the process of bone regeneration nearly a year
after implantation, they did not prevent slowdown of bone
regeneration and penetration of connective tissue into the
defect (ca. 23% of connective tissue versus ca. 14% of newly
formed bone covered the defect at the end of the experiment,
Table 3). Probably, the reason behind infiltration of fibrob-
lasts into the defect and the decrease in bone regeneration
rate that we observed was imperfect fixation of the outer
membrane to the bone. Improvement of fixation of the outer
membrane may influence the rate of bone regeneration. For
instance, Amano et al. [43] have demonstrated that, at the end
of a 36-week follow-up, the percentage of new bone filling
the space beneath the test membrane held by fixing pins was
greater than beneath the nonfixed membrane (62% versus
53%; 𝑝 < 0.05).
While the role of outer membrane in the process of bone
regeneration is well established, the applicability of inner
membrane placed between the dura and the inner surface
of calvarial bone is still an open question. Importantly, the
authors who used both outer and inner membranes observed
higher rate of bone regeneration and better organization of
newly formed bone trabeculae, which is a promising finding
[14, 41, 42]. Both membranes act as a barrier, protecting
the defect against connective tissue ingrowth and preventing
prolapse of the dura. Moreover, the use of two membranes
may be helpful in restoration of cranial curvature in the case
of larger defects. However, application of inner membrane
in our experiment may raise some questions, since, due
to characteristic shape and relatively small size of ovine
skull, artificially created bone defects were essentially flat and
round, and tense intact dura retained desirable shape of the
calvarium. Furthermore, histological analysis demonstrated
that bone trabeculae and immature bone matrix formed
primarily on the scaffold made of polylactide granules rather
than on themembranes.Therefore, it cannot be excluded that
the inner membrane did not promote bone regeneration but
could have even interfered with the osteoinductive effect of
the dura.
To sum up, our study have shown that implants made of
poly(L/DL-lactide) 80/20 have satisfactory biocompatibility
and most likely exert an osteoconductive effect together with
BioMed Research International 9
osteoinductive PRP, promoting bone regeneration within
large skull defects in sheep.
5. Conclusions
Implantation of poly(L/DL-lactide) 80/20 scaffolds in com-
bination with PRP acts synergistically as poly(L/DL-lactide)
80/20 provides osteoconduction (due to porosity of PLDLLA
implants) for the osteoinductivity of the PRP promoting bone
regeneration within large calvarial defect. These promising,
preliminary findings need to be verified in the future in a
larger group of animals followed up over a longer period
of time in order to draw definitive conclusions. In addition,
various forms of PLDLLA, that is, porous granules as a PRP
carrier and a membrane for defect closure, could be replaced
in the healing of bone defects with another form of the
membrane, such as a 3D-printed implant, which despite the
porosity also has biomechanical strength to accelerate cell
infiltration even after degradation of the material. Moreover,
the fixation of an outer polylactide membrane to bone edges
should be optimized to prevent connective tissue ingrowth
into the defect. Further improvements of bone regeneration
rate within large cranial defects might require application
of composite fillers made of polylactide polymers and other
materials with osseointegration properties, such as HAp or
calcium phosphate.
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